VIRTUAL EVENT
The only end-to-end forum solely dedicated to targeting inflammatory/regenerative pathways whilst overcoming challenges with drug delivery, safety and validated endpoints to bring about clinically effective dry-AMD therapies
The only end-to-end forum solely dedicated to targeting inflammatory/regenerative pathways whilst overcoming challenges with drug delivery, safety and validated endpoints to bring about clinically effective dry-AMD therapies
By signing up, you’re agreeing to receive email from SCB. But rest assured: we respect your privacy.